Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction
- 1 April 2011
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 300 (4) , H1274-H1281
Abstract
Caveolin (Cav)-1 has been involved in the pathogenesis of ischemic injuries. For instance, modulations of Cav-1 expression have been reported in animal models of myocardial infarction and cerebral ischemia-reperfusion. Furthermore, ablation of the Cav-1 gene in mice has been shown to increase the extent of ischemic injury in models of cerebral and hindlimb ischemia. Cav-1 has also been suggested to play a role in myocardial ischemic preconditioning. However, the role of Cav-1 in myocardial ischemia (MI)-induced cardiac dysfunction still remains to be determined. We determined the outcome of a permanent left anterior descending coronary artery (LAD) ligation in Cav-1 knockout (KO) mice. Wild-type (WT) and Cav-1 KO mice were subjected to permanent LAD ligation for 24 h. The progression of ischemic injury was monitored by echocardiography, hemodynamic measurements, 2,3,5-triphenyltetrazolium chloride staining, β-binding analysis, cAMP level measurements, and Western blot analyses. Cav-1 KO mice subjected to LAD ligation display reduced survival compared with WT mice. Despite similar infarct sizes, Cav-1 KO mice subjected to MI showed reduced left ventricular (LV) ejection fraction and fractional shortening as well as increased LV end-diastolic pressures compared with their WT counterparts. Mechanistically, Cav-1 KO mice subjected to MI exhibit reduced β-adrenergic receptor density at the plasma membrane as well as decreased cAMP levels and PKA phosphorylation. In conclusion, ablation of the Cav-1 gene exacerbates cardiac dysfunction and reduces survival in mice subjected to MI. Mechanistically, Cav-1 KO mice subjected to LAD ligation display abnormalities in β-adrenergic signaling.Keywords
This publication has 41 references indexed in Scilit:
- Differential involvement of caveolin-1 in brown adipocyte signaling: Impaired β3-adrenergic, but unaffected LPA, PDGF and EGF receptor signalingBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Myocardial Adeno-Associated Virus Serotype 6–βARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart FailureCirculation, 2009
- Freeze‐fracture replica immunolabelling reveals caveolin‐1 in the human cardiomyocyte plasma membraneJournal of Cellular and Molecular Medicine, 2008
- Matrix metalloproteinase‐2, caveolins, focal adhesion kinase and c‐Kit in cells of the mouse myocardiumJournal of Cellular and Molecular Medicine, 2007
- Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heartJournal of Molecular and Cellular Cardiology, 2007
- Caveolin-1 knockout alters β-adrenoceptors function in mouse small intestineAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I ReceptorJournal of Biological Chemistry, 2001
- Identification, sequence, and expression of caveolin-2 defines a caveolin gene family.Proceedings of the National Academy of Sciences, 1996
- Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in MuscleJournal of Biological Chemistry, 1996
- Caveolin, a protein component of caveolae membrane coatsCell, 1992